Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren Add-on to Valsartan/HCTZ in Diabetic Hypertensives
NCT00219102Phase 3Completed
- Sponsor
- Novartis
- Start
- Jun 2005
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of aliskiren in hypertension (HTN), sponsored by Novartis. Started Jun 2005; status: completed.
02
Drugs
aliskiren
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00219102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00219102.